Table: Oncolys Biopharma - 9-MTH parent results
Nov 7 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2025 Sep 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 28 mln 31 mln
(-9.0 pct) (-50.2 pct)
Operating loss 1.57 loss 1.23
Recurring loss 1.61 loss 1.24
Net loss 1.62 loss 1.25
EPS loss 64.63 yen loss 59.56 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T